Teva Pharmaceutical Industries Ltd is the largest generic drug manufacturer in the world with more than 60 manufacturing and R&D facilities, headquartered in Israel. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly one out of nine generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending FDA approval.
| Website: | www.tevapharm.com |
| Email: | kevin.mannix@tevapharm.com |
| Main Phone: | +972 39148171 |
| Address: | 5 Basel Street |
| Address 2: | P.O. Box 3190 |
| City / Town: | Petach Tikva |
| Country: | ISR |
| Postal Code: | 4951033 |
| Exchange: | NYE |
| CEO: | Kare Schultz |
| Employees: | 42535 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
Gathering Data... Please wait Teva Pharmaceutical Industries Ltd is the largest generic drug manufacturer in the world with more than 60 manufacturing and R&D facilities, headquartered in Israel. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly one out of nine generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent about half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending FDA approval.
| Website: | www.tevapharm.com |
| Email: | kevin.mannix@tevapharm.com |
| Main Phone: | +972 39148171 |
| Address: | 5 Basel Street |
| Address 2: | P.O. Box 3190 |
| City / Town: | Petach Tikva |
| Country: | ISR |
| Postal Code: | 4951033 |
| Exchange: | NYE |
| CEO: | Kare Schultz |
| Employees: | 42535 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 6.41 | Change $ 0.25 | Change % 4.06 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 6.21 | High 6.44 | Low 6.08 | Prev Close 6.16 |
| Last Trade | Volume 17.9 mi | 52 Wk Hi 25.96 | 52 Wk Low 6.07 |
| Market Cap 7 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 1,091,906,300.00 | EPS (TTM) -3.49 | PE Ratio N/A | Exchange NYSE |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 25 | 24 | 24 | 25 |
| Low Target Price Estimate | 13 | 13 | 13 | 13 |
| Mean Target Price Estimate | 18.1 | 17.43 | 17.53 | 18.35 |
| Standard Deviation | 3.24 | 3.01 | 2.81 | 3.05 |
| Date of Most Recent Estimate | 05/31/18 | 05/27/18 | 05/22/18 | 06/12/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 14 | 14 | 14 | 14 |
| Moderate Sell | 1 | 1 | 1 | 1 |
| Strong Sell | 6 | 6 | 6 | 6 |
| Mean Rec. | 3.29 | 3.29 | 3.29 | 3.29 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
